Patent ID: 7604939

Claim:
A method for identifying an active BRM expression-promoting histone deacetylase inhibitor that does not inactive BRM via acetylation and that specifically inhibits HDAC3 comprising; a) providing; i) a candidate histone deacetylase inhibitor; and ii) at least one cell, wherein said cell exhibits reduced BRM protein or BRM mRNA expression; b) contacting said cell with said candidate histone deacetylase inhibitor, c) measuring BRM protein or BRM mRNA expression exhibited by said cell, or measuring CD44 protein or CD44 mRNA expression exhibited by said cell, wherein an increase in said BRM protein expression, BRM mRNA expression, CD44 protein expression, or CD44 mRNA expression exhibited by said cell identifies said candidate histone deacetylase inhibitor as a BRM expression-promoting histone deactylase inhibitor; d) identifying said candidate histone deacetylase inhibitor as a BRM expression-promoting histone deactylase inhibitor; and e) determining that said BRM protein expressed after said contacting is active BRM protein capable of forming a functional SWI/SNF complex, thereby indentifying said BRM expression-promoting histone deacytlase inhibitor as an active BRM expression-promoting histone deacetylase inhibitor that does not inactivate BRM via acetylation and that specifically inhibits HDAC3.